Evidence map›Paper›PMID 26070485›Full record

ArticleImmunity2015

DC-SIGN(+) Macrophages Control the Induction of Transplantation Tolerance.

Patricia Conde, Mercedes Rodriguez, William van der Touw, Ana Jimenez, Matthew Burns, Jennifer Miller, Manisha Brahmachary, Hui-ming Chen, Peter Boros, Francisco Rausell-Palamos and 22 more

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 115 papers.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

115 citing papers in PubMed, 178 citations in OpenAlex.

  1. Immune Biomarkers of Islet Transplant Rejection Revealed by Synthetic Immunological Niche.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Review
  3. Article
  4. Synthetic Ligands of Myeloid C-Type Lectin Receptors.Chembiochem : a European journal of chemical biology · 2026
    Review
  5. Review
  6. Article
  7. Suppression of cardiac allograft vasculopathy by a macrophage efferocytosis receptor.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Delivery of butyrate to the lower gut by polymeric micelles prolongs survival of distal skin allografts.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2025
    Article

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

32 authors at 16 institutions in 9 countries.

Patricia CondeDepartment of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10129, USA.
Mercedes RodriguezImmunología de Trasplantes, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid 28220, Spain.
William van der TouwDepartment of Oncological Sciences Icahn School of Medicine at Mount Sinai, New York, NY 10129, USA.
Ana JimenezDepartment of Oncological Sciences Icahn School of Medicine at Mount Sinai, New York, NY 10129, USA.
Matthew BurnsDepartment of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10129, USA.
Jennifer MillerDepartment of Oncological Sciences Icahn School of Medicine at Mount Sinai, New York, NY 10129, USA.
Manisha BrahmacharyDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10129, USA.
Hui-ming ChenDepartment of Oncological Sciences Icahn School of Medicine at Mount Sinai, New York, NY 10129, USA.
Peter BorosDepartment of Surgery, Icahn School of Medicine at Mount Sinai, New York, NY 10129, USA.
Francisco Rausell-PalamosDiabetes Obesity and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10129, USA.
Tae Jin YunInstitut de Researches Cliniques de Montréal, Montréal, Québec H2W1R7, Canada.
Paloma RiquelmeDepartment of Surgery, University Hospital Regensburg, Regensburg 93053, Germany.
Alberto RastrojoCentro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, Madrid 28049, Spain.
Begoña AguadoCentro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, Madrid 28049, Spain.
Joan Stein-StreileinSchepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School, Boston, MA 02114, USA.
Masato TanakaLaboratory of Immune Regulation, Tokyo University of Pharmacy and Life Sciences, Tokyo 192-0392, Japan.
Lan ZhouDepartment of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.
Junfeng ZhangAlberta Glycomics Centre and Department of Chemistry, University of Alberta, Edmonton T6G 2G2, Canada.
Todd L LowaryAlberta Glycomics Centre and Department of Chemistry, University of Alberta, Edmonton T6G 2G2, Canada.
Florent GinhouxSingapore Immunology Network, Agency for Science Technology and Research, Singapore 138648, Singapore.
Chae Gyu ParkLaboratory of Immunology, Yonsei University College of Medicine, Seoul 120-752, Korea.
Cheolho CheongInstitut de Researches Cliniques de Montréal, Montréal, Québec H2W1R7, Canada.
Joshua BrodyDepartment of Oncological Sciences Icahn School of Medicine at Mount Sinai, New York, NY 10129, USA.
Shannon J TurleyDepartment of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA 02284, USA.
Sergio A LiraImmunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10129, USA.
Vincenzo BronteVerona University Hospital, Verona 37129, Italy.
Siamon GordonSir William Dunn School of Pathology, University of Oxford, Oxford OX1 2JD, England.
Peter S HeegerDepartment of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10129, USA.
Miriam MeradDepartment of Oncological Sciences Icahn School of Medicine at Mount Sinai, New York, NY 10129, USA.
James HutchinsonDepartment of Surgery, University Hospital Regensburg, Regensburg 93053, Germany.
Shu-Hsia ChenDepartment of Oncological Sciences Icahn School of Medicine at Mount Sinai, New York, NY 10129, USA.
Jordi OchandoDepartment of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10129, USA; Immunología de Trasplantes, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid 28220, Spain. Electronic address: jordi.ochando@mssm.edu.
Icahn School of Medicine at Mount Sinai · USMontreal Clinical Research Institute · CAUniversity Hospital Regensburg · DEAlberta Glycomics Centre · CACase Western Reserve University · USCentro de Biología Molecular Severo Ochoa · ESConsejo Superior de Investigaciones Científicas · ESDana-Farber Cancer Institute · USInstituto de Salud Carlos III · ESSingapore Immunology Network · SGSmith-Kettlewell Eye Research Institute · USTokyo University of Pharmacy and Life Sciences · JPUniversity of Alberta · CAUniversity of Oxford · GBUniversity of Verona · ITYonsei University · KR

Funding

Intervention of immune tolerance by small molecules to enhance immune therapyR01CA127483 · NCI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI CHEN, SHU-HSIA · 2008 to 2018
$3.4M
Myeloid Suppressor Cell-Mediated Immune Suppression of Tumor Specific T CellsR01CA109322 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CHEN, SHU-HSIA · 2006 to 2015
$3.2M
Contribution of the cutaneous APC network to melanoma progression and therapy.R01CA173861 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MERAD, MIRIAM · 2013 to 2017
$2.1M
Harnessing Csf-2 compartmentalized role on tissue resident phagocytes to uncouple anti-tumoral from pathological immunity induced by checkpoint inhibitorsR01CA190400 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MERAD, MIRIAM · 2015 to 2019
$1.9M
NCI NIH HHS R01 CA109322NCI NIH HHS R01 CA127483NCI NIH HHS R01 CA173861NCI NIH HHS R01 CA190400
6 · The paper itself

Abstract

Tissue effector cells of the monocyte lineage can differentiate into different cell types with specific cell function depending on their environment. The phenotype, developmental requirements, and functional mechanisms of immune protective macrophages that mediate the induction of transplantation tolerance remain elusive. Here, we demonstrate that costimulatory blockade favored accumulation of DC-SIGN-expressing macrophages that inhibited CD8(+) T cell immunity and promoted CD4(+)Foxp3(+) Treg cell expansion in numbers. Mechanistically, that simultaneous DC-SIGN engagement by fucosylated ligands and TLR4 signaling was required for production of immunoregulatory IL-10 associated with prolonged allograft survival. Deletion of DC-SIGN-expressing macrophages in vivo, interfering with their CSF1-dependent development, or preventing the DC-SIGN signaling pathway abrogated tolerance. Together, the results provide new insights into the tolerogenic effects of costimulatory blockade and identify DC-SIGN(+) suppressive macrophages as crucial mediators of immunological tolerance with the concomitant therapeutic implications in the clinic.

Indexed as

Heart TransplantationAnimalsCD8-Positive T-LymphocytesCell Adhesion MoleculesCells, CulturedDC-Specific ICAM-3 Grabbing NonintegrinForkhead Transcription FactorsGraft RejectionImmune ToleranceInterleukin-10Lectins, C-TypeMacrophage Colony-Stimulating FactorMacrophagesMiceMice, Inbred BALB CMice, Inbred C57BLCell Adhesion MoleculesDC-Specific ICAM-3 Grabbing NonintegrinForkhead Transcription FactorsFoxp3 protein, mouseInterleukin-10Lectins, C-TypeMacrophage Colony-Stimulating FactorReceptors, Cell SurfaceToll-Like Receptor 4

Identifiers

PMID26070485
PMCPMC4690204
OpenAlexW1944352258

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.